We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The past 3 years of collaboration have resulted in multiple positive outcomes, for research and better patient care. One success was the use of Holmusk's proprietary analytics methodology to predict the risk of secondary major adverse cardiovascular event